Cargando…

Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma

This cohort study examines the risk of skeletal-related events associated with the frequency of bisphosphonate treatment in patients with multiple myeloma.

Detalles Bibliográficos
Autores principales:	Zhou, Jifang, Sweiss, Karen, Han, Jin, Ko, Naomi Y., Patel, Pritesh R., Chiu, Brian C.-H., Calip, Gregory S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316999/ https://www.ncbi.nlm.nih.gov/pubmed/34313746 http://dx.doi.org/10.1001/jamanetworkopen.2021.18410

Ejemplares similares

Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications
por: Bahk, Ji Hoon, et al.
Publicado: (2023)

Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults
por: Guadamuz, Jenny S., et al.
Publicado: (2019)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bilateral Atypical Femoral Fractures in a Patient with Multiple Myeloma Treated with Intravenous Bisphosphonate Therapy
por: Tonogai, Ichiro, et al.
Publicado: (2014)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Paradoxical Stress Fracture in a Patient With Multiple Myeloma and Bisphosphonate Use
por: Chiu, Edwin, et al.
Publicado: (2020)

Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
por: Calip, Gregory S., et al.
Publicado: (2022)

Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study
por: Asfaw, Alemseged Ayele, et al.
Publicado: (2018)

Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005)

Multiple Myeloma and the Role of Bisphosphonates in Its Management
por: Tanveer, Nida, et al.
Publicado: (2023)

Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race
por: Zhou, Jifang, et al.
Publicado: (2021)

Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Sweiss, Karen, et al.
Publicado: (2016)

Paget's Disease: Skeletal Manifestations and Effect of Bisphosphonates
por: Kang, Ho, et al.
Publicado: (2017)

Computed Tomography-Based Investigation on the Effects of Intravenous Bisphosphonate Administration on Tooth Growth in a Minipig Animal Model
por: Poxleitner, Philipp, et al.
Publicado: (2022)

Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies
por: Sweiss, Karen, et al.
Publicado: (2021)

Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients
por: Kim, Hye-Won, et al.
Publicado: (2021)

Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding ‘risks and benefits of bisphosphonates’
por: Kyrgidis, A, et al.
Publicado: (2009)

Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients
por: Walter, Christian, et al.
Publicado: (2010)

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

Sickle cell bone disease and response to intravenous bisphosphonates in children
por: Grimbly, C., et al.
Publicado: (2022)

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Multiple Myeloma and Bisphosphonate-Related Osteonecrosis of the Mandible Associated with Dental Implants
por: Junquera, Luis, et al.
Publicado: (2011)

Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
por: Melea, Pelagia I., et al.
Publicado: (2014)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Regeneration of Cochlear Synapses by Systemic Administration of a Bisphosphonate
por: Seist, Richard, et al.
Publicado: (2020)

Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
por: Karakousis, Vasileios Alexandros, et al.
Publicado: (2020)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
por: Lee, Seung-Hun, et al.
Publicado: (2021)

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers
por: Soefje, Scott A., et al.
Publicado: (2023)

Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma
por: Parrondo, Ricardo D, et al.
Publicado: (2019)

Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma
por: Roose, James, et al.
Publicado: (2022)

Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991–2011
por: Solanki, Pooja A., et al.
Publicado: (2016)

Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
por: Kos, Marcin
Publicado: (2015)

Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates
por: Bermúdez-Bejarano, Elena-Beatriz, et al.
Publicado: (2017)

SAT-LB052 Intravenous Bisphosphonate Therapy in Children with Spinal Muscular Atrophy
por: Nasomyont, Nat, et al.
Publicado: (2019)

ODP124 Sickle Cell Bone Disease and Response to Intravenous Bisphosphonates in Children
por: Todd Alexander, R, et al.
Publicado: (2022)

Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
por: Bishop, Simon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mn97mfjr4hcsqoqou4iv01p8f8